Zimmer Biomet has ended its license agreement with Bactiguard for some orthopedic products, the infection prevention company said Oct. 2.
Zimmer Biomet’s reason was because of “the more complex and lengthier path with the US Food and Drug Administration (FDA) than initially expected,” Bactiguard said in a news release. The companies have been in partnership for orthopedic products since 2022.
The partnership will remain intact for Zimmer Biomet’s trauma product segment, which was signed in 2019.
Aurora Spine earned FDA 510(k) clearance for its Aero facet fusion system, the devicemaker said March 25. Aero is a…
Tenon Medical earned FDA 510(k) clearance to use its Catamaran sacroiliac joint system for augmenting thoracolumbar fusion, according to a…
SynerFuse is partnering with Velentium Medical to scale the SynerFuse e-TLIF implant, according to a March 21 news release. Velentium…
Comments are closed.